{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,13]],"date-time":"2026-09-13T23:47:31Z","timestamp":1789343251942,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.semarthrit.2023.152265","type":"journal-article","created":{"date-parts":[[2023,10,7]],"date-time":"2023-10-07T03:07:41Z","timestamp":1696648061000},"page":"152265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Pulmonary involvement in catastrophic antiphospholipid syndrome: A descriptive analysis from the \u201cCAPS Registry\u201d"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2479-4285","authenticated-orcid":false,"given":"Ana","family":"Ponce","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignasi","family":"Rodr\u00edguez-Pint\u00f3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Quintas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doruk","family":"Erkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yehuda","family":"Shoenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricard","family":"Cervera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2023.152265_bib0001","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/00005792-199805000-00005","article-title":"Catastrophic antiphospholipid syndrome. clinical and laboratory features of 50 patient","volume":"77","author":"Asherson","year":"1998","journal-title":"Medicine"},{"key":"10.1016\/j.semarthrit.2023.152265_bib0002","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/00005792-200111000-00002","article-title":"Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients","volume":"80","author":"Asherson","year":"2001","journal-title":"Medicine"},{"key":"10.1016\/j.semarthrit.2023.152265_bib0003","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1177\/0961203313491024","article-title":"Catastrophic antiphospholipid syndrome with concurrent thrombotic and hemorrhagic manifestations","volume":"22","author":"- Rangel","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2023.152265_bib0004","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/j.autrev.2016.09.010","article-title":"Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of 500 patients from the International CAPS Registry","volume":"15","author":"- Rodriguez-Pinto","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2023.152265_bib0005","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/915309","article-title":"Catastrophic antiphospholipid syndrome with severe acute thrombotic microangiopathy and hemorrhagic complications","volume":"2013","author":"Vieregge","year":"2013","journal-title":"Case Rep Med"},{"key":"10.1016\/j.semarthrit.2023.152265_bib0006","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/00124743-200102000-00007","article-title":"Recurrent alveolar hemorrhage and pul monary capillaritis in the \u2018primary\u2019 antiphospholipid syndrome","volume":"7","author":"Asherson","year":"2001","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2023.152265_bib0007","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1097\/00002281-200101000-00003","article-title":"Diffuse alveolar hemorrhage syndromes","volume":"13","author":"Specks","year":"2001","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.semarthrit.2023.152265_bib0008","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1136\/ard.61.3.195","article-title":"The lung in the antiphospholipid syndrome","volume":"61","author":"Espinosa","year":"2002","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2023.152265_bib0009","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1191\/0961203303lu394oa","article-title":"Catastrophic antiphospholipid syndrome: international consensus statement on classification criteria and treatment guidelines","volume":"12","author":"Asherson","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.semarthrit.2023.152265_bib0010","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.autrev.2010.08.005","article-title":"Catastrophic antiphospholipid syndrome: updated diagnostic algorithms","volume":"10","author":"Erkan","year":"2010","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2023.152265_bib0011","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1136\/ard.2004.025759","article-title":"Validation of the preliminary criteria for the classification of catastrophic antiphospholipid syndrome","volume":"64","author":"Cervera","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.semarthrit.2023.152265_bib0012","series-title":"Diagn\u00f3stico por imagen: tratado de radiolog\u00eda cl\u00ednica","author":"Pedrosa","year":"2004"},{"key":"10.1016\/j.semarthrit.2023.152265_bib0013","first-page":"97","article-title":"Patrones radiol\u00f3gicos en la enfermedad pulmonar intersticial. de Reumatolog\u00eda","volume":"14","author":"Gim\u00e9nez","year":"2013","journal-title":"Semin Fund Esp"},{"key":"10.1016\/j.semarthrit.2023.152265_bib0014","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.rcl.2005.01.010","article-title":"High-resolution CT of the lung: patterns of disease and differential diagnoses","volume":"43","author":"Gotway","year":"2005","journal-title":"Radiol Clin North Am"},{"key":"10.1016\/j.semarthrit.2023.152265_bib0015","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.semarthrit.2005.05.006","article-title":"Antiphospholipid antibodies as a cause of pulmonary capillaritis and diffuse alveolar hemorrhage: a case series and literature review","volume":"35","author":"Deane","year":"2005","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2023.152265_bib0016","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.transci.2011.07.002","article-title":"Thrombotic microangiopathy","volume":"45","author":"M\u00f6rtzell","year":"2011","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.semarthrit.2023.152265_bib0017","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/394740","article-title":"Arterial and venous thrombosis in cancer patients","volume":"2011","author":"Blann","year":"2011","journal-title":"Cardiol Res Pract"},{"issue":"10","key":"10.1016\/j.semarthrit.2023.152265_bib0018","doi-asserted-by":"crossref","DOI":"10.1007\/s11926-019-0852-7","article-title":"Clinical insights into diffuse alveolar hemorrhage in antiphospholipid syndrome","volume":"21","author":"Stoots","year":"2019","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.semarthrit.2023.152265_bib0019","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMra2026131","volume":"383","author":"Fajgenbaum","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.semarthrit.2023.152265_bib0020","first-page":"160","article-title":"New approaches for managing antiphospholipid syndrome","volume":"5","author":"Erkan","year":"2009","journal-title":"Nat Clin Pract Rheumatol"},{"key":"10.1016\/j.semarthrit.2023.152265_bib0021","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2008.10.003","article-title":"The physiopathology of the catastrophic antiphospholipid (Asherson's) syndrome: compelling evidence","volume":"32","author":"Ortega-Hernandez","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.semarthrit.2023.152265_bib0022","first-page":"585","article-title":"Catastrophic antiphospholipid syndrome: an orchestra with several musicians","volume":"16","author":"Rodr\u00edguez-Pint\u00f3","year":"2014","journal-title":"Isr Med Assoc J"},{"key":"10.1016\/j.semarthrit.2023.152265_bib0023","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11926-020-00935-2","article-title":"Management of Non-criteria Manifestations in antiphospholipid syndrome","volume":"22","author":"Xourgia","year":"2020","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.semarthrit.2023.152265_bib0024","first-page":"2526","article-title":"Acute respiratory distress syndrome: the berlin definition","volume":"307","author":"Definition Task Force","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.semarthrit.2023.152265_bib0025","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1164\/ajrccm.165.2.ats01","volume":"165","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.semarthrit.2023.152265_bib0026","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American thoracic society\/European respiratory society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.semarthrit.2023.152265_bib0027","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/rheumatology\/key082","article-title":"CAPS registry project group. the effect of triple therapy on the mortality of catastrophic anti-phospholipid syndrome patients","volume":"57","author":"Rodr\u00edguez-Pint\u00f3","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2023.152265_bib0028","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1002\/art.41891","article-title":"Expert Perspective: management of Microvascular and Catastrophic Antiphospholipid Syndrome","volume":"73","author":"Erkan","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.semarthrit.2023.152265_bib0029","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.healun.2021.10.016","article-title":"Chronic thromboembolic pulmonary hypertension in patients with antiphospholipid syndrome: risk factors and management","volume":"41","author":"Rosen","year":"2022","journal-title":"J Heart Lung Transpl"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017223001075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017223001075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:12:45Z","timestamp":1758733965000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017223001075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":29,"alternative-id":["S0049017223001075"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152265","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pulmonary involvement in catastrophic antiphospholipid syndrome: A descriptive analysis from the \u201cCAPS Registry\u201d","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2023.152265","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152265"}}